Novel adipocytokines such as omentin, vaspin, and chemerin exhibit protective vascular properties, highlighting their potential as future therapeutic targets for obesity-related metabolic vascular disorders.
Answers are grounded in this paper and cite their sources.
May identify novel targets for obesity-related vascular disease; hypothesis-generating and requires validation before clinical consideration.
Adipose tissue is now regarded as an active endocrine organ which can secrete various cytokines. Adipocyte-derived cytokines are termed adipocytokines (adipocytes+cytokine). Adipocytokines can affect vascular systems to prevent or exacerbate obesity-related vascular complications, including diabetes-related vascular dysfunction, hypertension, and atherosclerosis. However, their basic vascular functions remain to be fully determined. In this manuscript, I summarize our recent findings on the vascular effects of 5 newly identified adipocytokines (omentin, visfatin, nesfatin, vaspin, and chemerin), with a special focus on 1) vascular contractile reactivity, and 2) vascular inflammatory response/injury. These novel adipocytokines may be important future targets for the development of drugs and therapy for treating metabolic vascular disorders.
No takes yet. Share an insight, caveat, or question.
Hideyuki Yamawaki (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: